ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,601,792 | +2215.3% | 268,800 | +1990.9% | 0.13% | +2580.0% |
| Q1 2023 | $241,950 | -73.8% | 12,856 | -77.9% | 0.01% | -76.2% |
| Q4 2022 | $925,095 | -2.7% | 58,109 | 0.0% | 0.02% | -12.5% |
| Q3 2022 | $951,000 | +101.5% | 58,109 | +104.4% | 0.02% | +84.6% |
| Q3 2021 | $472,000 | -45.7% | 28,434 | -20.2% | 0.01% | -53.6% |
| Q2 2021 | $869,000 | +93.5% | 35,627 | +104.7% | 0.03% | +64.7% |
| Q1 2021 | $449,000 | +45.3% | 17,402 | +201.0% | 0.02% | +54.5% |
| Q4 2020 | $309,000 | +12.4% | 5,781 | -13.4% | 0.01% | -35.3% |
| Q3 2020 | $275,000 | -11.0% | 6,672 | -55.2% | 0.02% | -45.2% |
| Q3 2018 | $309,000 | – | 14,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |